Value through Innovation27 July 2016

What is a lay summary?

Clinical Study Results

  • GIOTRIF ® (afatinib) - Liver Diseases
    Clinical Study Number 1200.86
    Study Indication Liver Diseases
    Product GIOTRIF ® (afatinib)
    Generic Name Afatinib
    Lab Code
    Clinical Phase I
    Study Title

    Pharmacokinetics, safety and tolerability of different oral doses of afatinib, in  subjects with mild to moderate hepatic impairment compared to healthy   subjects—a phase I, single-dose, open-label, dose-escalation study in a matched   group design

    Study Document
    Trial synopsis 1200.86 english